To ensure consistency and efficiency of assessments related to chemicals provided for in Union legal acts, the relevant Union agencies should take measures to avoid divergent scientific opinions. Instances of divergent scientific opinions have led to increased uncertainty for operators, as well as to a decrease in public trust in the robustness and consistency of scientific decision making. Proposals to address and strengthen procedures for resolving divergences of scientific opinion between the European Medicines Agency and other scientific bodies have been made as part of the revision of Union pharmaceutical legislation. The proposal of similar provisions in the Regulation on the European Chemicals Agency could also be considered, in order to ensure that provisions for solving divergent scientific opinions between all relevant Union agencies are consistent. No such additional provisions would be necessary as regards the EEA, since the EEA does not issue scientific opinions on individual chemicals.
Text as published in the Official Journal, reproduced verbatim (including any typographical quirks of the source). For the authentic version, see EUR-Lex.
